GlassScriptPhysician profile
Joseph M Karch
NPI 1588873640
$286.82
in general payments reported to CMS, 2019-2025
11 companies · $62.79 in 2025
The $62.79 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.80 · 2023: $49.91 · 2024: $156 · 2025: $62.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $58.72 | 2024 | Accolade Sr, Resonate El Icd Vr |
| Intuitive Surgical, INC. | $51.21 | 2024 | |
| Enterra Medical, INC. | $27.55 | 2024 | |
| Davol INC. | $25.96 | 2025 | Phasix Mesh |
| Kerecis Limited | $23.19 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Innovation Technologies INC | $18.84 | 2024 | Irrisept |
| W. L. Gore & Associates, INC. | $17.80 | 2019 | |
| Myriad Genetic Laboratories, INC. | $17.77 | 2023 | Myrisk |
| Abbvie INC. | $16.92 | 2023 | |
| Medtronic, INC. | $15.22 | 2023 | Progrip |
| Urgo Medical North America, LLC | $13.64 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Karch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.